No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines (DREAM) study
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Mary E Ritchey Sebastian Schneeweiss |
| Publication date | October 4, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |